Retatrutide Public Source Tracker
Retatrutide is investigational and is not approved for public use. This page is for regulatory awareness, public-source documentation, and safety research only. It is not buying guidance and does not recommend, rank, verify, endorse, source, import, prescribe, sell, or facilitate access to any product.

Status

Retatrutide approval status checker

Published May 3, 2026Updated May 3, 2026Informational tool

As checked on May 3, 2026, retatrutide is investigational and is not FDA approved for public sale or prescription.

Current status

FDA approvalNo FDA-approved public retatrutide product

Retatrutide is investigational and not approved for public sale or prescription.

Official status context

Official access contextLilly clinical trials only

Lilly says retatrutide is legally available only to clinical trial participants.

Next check

  • Read official FDA and Lilly sources before relying on marketplace claims.
  • Use the trial finder for ClinicalTrials.gov records.
  • Use approved alternatives for clinician-supervised options.

Medical disclaimer

This tool is for informational purposes only and does not constitute medical advice. I am not a medical professional. Always consult a qualified healthcare provider before starting, stopping, or changing any weight loss treatment. Retatrutide is investigational and is not FDA approved.

Sources

Related pages